Home › Funds › Nicholas Investment Partners, LP › CYTK
Nicholas Investment Partners, LP position in CYTK
CYTOKINETICS INC COM NEW · Health Care
Nicholas Investment Partners, LP reported holding 209,071 shares of CYTK (CYTOKINETICS INC COM NEW) in its Q2 2026 13F filing — a position valued at US$17.8M, representing 1.12% of its reported portfolio and ranking #22 among its reported holdings. Nicholas Investment Partners, LP has disclosed CYTK holdings in 11 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Nicholas Investment Partners, LP's CYTK position evolved
Nicholas Investment Partners, LP first disclosed a stake in CYTK in Q3 2023 at 2,500,000 shares (US$2.1M). The position peaked in Q2 2026 at 209,071 shares, worth US$17.8M. Across 11 filings, Nicholas Investment Partners, LP increased the stake 4 time(s), trimmed it 2 time(s) and left it unchanged 3 time(s). The most recent filing (Q2 2026) shows 209,071 shares valued at US$17.8M — an increase of 139,226 shares quarter over quarter.. Notable position changes include a 100% trim in Q3 2024 (shares fell 11% over the following quarter), a 29314% increase in Q1 2025 (shares fell 18% over the following quarter), a 199% increase in Q2 2026 (shares fell 23% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 2.50M | $2.12M | New |
| Q4 2023 | 3.00M | $5.26M | Add |
| Q1 2024 | 3.00M | $4.76M | Hold |
| Q2 2024 | 3.00M | $3.91M | Hold |
| Q3 2024 | 11.05K | $583.39K | Reduce |
| Q4 2024 | 11.05K | $519.75K | Hold |
| Q1 2025 | 3.25M | $3.72M | Add |
| Q3 2025 | 62.12K | $3.41M | New |
| Q4 2025 | 70.24K | $4.46M | Add |
| Q1 2026 | 69.84K | $4.60M | Reduce |
| Q2 2026 | 209.07K | $17.81M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CYTK and 13F data
CYTK (CYTOKINETICS INC COM NEW) is a Health Care company. 52 other funds we track also report a position in CYTK — the largest reported positions include T. Rowe Price Investment Management, Inc. (US$1.59B), Avoro Capital Advisors LLC (US$425.9M), RTW INVESTMENTS, LP (US$243.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CYTK
- T. Rowe Price Investment Management, Inc. 18.72M sh · $1.59B · Q2 2026
- Avoro Capital Advisors LLC 5.00M sh · $425.95M · Q2 2026
- RTW INVESTMENTS, LP 2.86M sh · $243.81M · Q2 2026
- Polar Capital Holdings Plc 2.25M sh · $191.99M · Q2 2026
- Integral Health Asset Management, LLC 1.60M sh · $136.30M · Q2 2026
- ARMISTICE CAPITAL, LLC 1.20M sh · $102.34M · Q2 2026
- Frazier Life Sciences Management, L.P. 1.16M sh · $98.81M · Q2 2026
- Royalty Pharma Sub-Manager, LLC 980.39K sh · $83.52M · Q2 2026
- GW&K Investment Management, LLC 916.11K sh · $78.04M · Q2 2026
- Melqart Asset Management (UK) Ltd 767.52K sh · $65.39M · Q2 2026
- Siren, L.L.C. 758.95K sh · $64.66M · Q2 2026
- Foresite Capital Management IV, LLC 714.70K sh · $60.88M · Q2 2026
More on Nicholas Investment Partners, LP
FAQ
How long has Nicholas Investment Partners, LP held CYTK?
Nicholas Investment Partners, LP has disclosed CYTK holdings in 11 of the last 12 reported quarters, going back to Q3 2023.
What is Nicholas Investment Partners, LP's current position in CYTK?
As of Q2 2026, Nicholas Investment Partners, LP holds 209.07K shares of CYTK (CYTOKINETICS INC COM NEW), valued at $17.81M, representing 1.12% of its reported portfolio and ranking #22.
Has Nicholas Investment Partners, LP been buying or selling CYTK?
In the latest 13F filing (Q2 2026), Nicholas Investment Partners, LP increased its position in CYTK. The position peaked in Q2 2026 at 209.07K shares.
Which other funds hold CYTK?
Other major institutional holders of CYTK include T. Rowe Price Investment Management, Inc., Avoro Capital Advisors LLC, RTW INVESTMENTS, LP, among 52 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.